Dear Patients, Patient’s Loved Ones and Friends,
Since I ended my hunger strike, I have learned that the FDA has sent invitations for the ME/CFS scientific stakeholder workshop scheduled for April 25-26th. The FDA hasn’t disclosed who it is inviting, and did not solicit input from patients. You, Read more [...]
(In 2010 Kelvin Lord dragged himself into Dr. Lapp's office in a last-ditch effort to recover his failing health. A year of Ampligen infusions and 30 plus often hilarious and poignant blogs later he signed off with a blog in Jan, 2011, "Learning to Fly Again" , charting his gains. '
He Read more [...]
We, as a community, accomplished some very important things during the last few weeks, and so I am ending my hunger strike tonight. I am committed to working with our federal health agencies to bring a stronger focus and program to bear on ME/CFS for all of us. The most important Read more [...]
Hemispherx released a statement on Monday indicating the FDA had denied their application of Ampligen to treat Chronic Fatigue Syndrome (ME/CFS) because of lack of 'substantial' proof of efficacy and (rather ominously) because they did not have enough data to assess safety concerns.
The Read more [...]
Ask Secretary Sebelius to start NIH Clinical Trial of Ampligen
Contact: Robert Miller 703-554-5575, Courtney Miller 631-834-4681
In day 8 of his hunger strike, Chronic Fatigue Syndrome patient Robert Miller decried the FDA’s decision (announced hours ago) to disapprove Ampligen, Read more [...]
The plight of the chronic fatigue syndrome community was given a sympathetic and moving portrayal in a TV news story in Reno yesterday that featured Bob Miller and Dr. Janet Smith, another Ampligen recipient. The news organization contacted both the FDA and Hemispherx regarding the story. Read more [...]
Bob Miller has been to the Vice President's office, he's had one and one meetings with the Director of the NIH, he's canvassed politicians on the Hill - he's thrown everything he can into the fight to get this disorder recognition - but this time, the issue - the probable FDA rejection of Ampligen Read more [...]
Check out Part I of this series ('FDA Advisory Committee Meeting on Ampligen Pt I: Dueling Presentation Set Stage for Critical Vote') on the Simmaron Foundations Website here
While the FDA statistical team was highly critical of the drug, the FDA put together a Committee that Read more [...]